This study proves that YCLLT was able to attenuate lipid deposition, inhibit inflammatory response, and ameliorate mitochondrial dysfunction in a NAFLD cell model, and the mechanism of its action may be related to the AdipoR1/AMPK/SIRT1 signaling pathway. The gene discussed is ADIPOR1; the disease is metabolic dysfunction-associated steatotic liver disease.